PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
58.47
ESG score 90-95% of ANVS's 62.21. Bill Ackman would demand clear ESG improvement catalysts.
53.73
Environmental score 1.1-1.2x ANVS's 47.17. Guy Spier would verify if superior environmental practices translate to better regulatory positioning.
61.12
Similar social score to ANVS's 64.21. Bruce Berkowitz would investigate if industry social norms adequately address stakeholder expectations.
60.56
Governance score 80-90% of ANVS's 75.24. Walter Schloss would scrutinize management accountability and board independence.